文献速递介入外周血管DSA

使用定向斑块旋切术对腔内肿瘤进行经皮血管内组织采样

Percutaneous endovascular tissue sampling of endoluminal tumors using directional atherectomy.
PubMed 文献 · Eur Radiol · 2019-02-22

该研究纳入2013至2017年间连续10例需血管内肿块采样的患者,在同一操作中依次应用导管抽吸、双钳活检钳和定向斑块旋切三种方法。抽吸和活检钳均未获得足够组织学分析材料,而定向斑块旋切技术成功率为100%,两次旋切后各血管区域均获得足够材料明确组织学诊断。未记录到血管穿孔等操作相关并发症,作者认为定向斑块旋切安全可行,但需进一步大规模研究评估。

要点

  • 定向斑块旋切对血管内肿块组织采样技术成功率为100%,两次旋切后均可获得足够组织学诊断材料。
  • 导管抽吸和双钳活检钳均未能提供足够材料进行组织学分析。
  • 未记录到血管穿孔等操作相关并发症,假阴性率考虑为0%。

核心结论

  • 在有限例数的初步结果中,定向斑块旋切被证明是血管内肿块腔内组织采样安全且可行的技术,但需进一步大规模研究评估。

研究设计与样本

  • 2013至2017年间连续纳入10例患者(6例男性,中位年龄56岁,范围39-73岁),对腹部主动脉(4例)、左头臂静脉(2例)、下腔静脉(1例)和左肺动脉(3例)的血管内肿块,在同一操作中依次应用导管抽吸、双钳活检钳和定向斑块旋切三种血管内组织采样方法。

诊断标准与关键数值

  • 定向斑块旋切技术成功率为100%。
  • 两次旋切后各血管区域均获得足够材料进行组织学诊断。
  • 组织学良性诊断者随访3个月和1年影像学未见明显恶性肿瘤增殖,假阴性率考虑为0%。

临床应用与阅片要点

  • 作者认为定向斑块旋切可能作为进一步治疗决策前组织探查的最后或唯一选择。
  • 导管抽吸和双钳活检钳在本研究队列中未能提供足够组织学分析材料,定向斑块旋切优于抽吸或活检钳。
  • 原文未据此给出常规临床应用推荐。

局限性

  • 原文指出为有限例数患者的初步结果。
  • 原文指出需要进一步大规模研究并在临床实践中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate technical feasibility and safety of endovascular tumor specimen sampling using an escalating endovascular biopsy strategy using a directional atherectomy device compared with forceps biopsy and catheter aspiration.

MATERIALS AND METHODS: Between 2013 and 2017, a cohort of ten consecutive patients (6 male; median age 56, range 39-73 years) was referred for sampling of endovascular masses. Localizations included the abdominal aorta (n = 4), left brachiocephalic vein (n = 2), inferior vena cava (n = 1), and left pulmonary artery (n = 3). For each individual mass, all three endovascular tissue sampling approaches were applied including catheter-based aspiration, straight two-jaw biopsy forceps, and directional atherectomy during a single session.

RESULTS: Aspiration and forceps biopsy did not provide sufficient material for histological analyses. In contrast, technical success for endovascular tumor sampling using directional atherectomy was 100%. After two atherectomy passages, sufficient material was available for each vessel region allowing histologic diagnosis, which revealed sarcoma and chronic inflammation for masses in the aorta, angiosarcoma for brachiocephalic vein, hepatocellular carcinoma for inferior vena cava, and angiosarcoma for pulmonary artery. In case of a histologically benign diagnosis, no malignant tumor proliferation was obvious on follow-up imaging studies after 3 months and 1 year. Thus, the rate of false-negative results was considered 0%. No procedure-associated complications, e.g., vessel perforation, were recorded.

CONCLUSION: Preliminary results in a limited number of patients proved directional atherectomy beneficial as a safe and feasible technique for endoluminal tissue sampling of vascular masses. Additional large-scale studies are necessary and worthy for further evaluation in clinical practice.

KEY POINTS: • Endovascular masses pose a challenge to appropriate clinical management. • Off-label directional atherectomy proved to be a safe and feasible technique for endoluminal tissue sampling of vascular masses. Furthermore, directional atherectomy was superior to aspiration or forceps biopsy in our small study cohort. • Directional atherectomy may represent the last or only option for tissue probing as a prerequisite for further treatment decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Massmann A, Seidel R, Schneider GK, et al. Percutaneous endovascular tissue sampling of endoluminal tumors using directional atherectomy. Eur Radiol. 2019. PMID: 30796569. doi:10.1007/s00330-019-06015-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。